Tyrosine

Tyrosine

SCHEMBL1495262

N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 3/20 0.64
SLC7A5 Q01650 1/20 0.60
FOLH1 Q04609 3/20 0.49
YARS1 P54577 2/20 0.48
ENPEP Q07075 2/20 0.47
ACE P12821 1/20 0.46
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46
NPY4R P50391 1/20 0.46
POLB P06746 1/20 0.46
BACE1 P56817 1/20 0.46
BACE2 Q9Y5Z0 1/20 0.46
MME P08473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tyrosine SCHEMBL1495323 0.98 NAALAD2 (0.62) NAALAD2SLC7A5FOLH1YARS1ENPEP
Tyrosine SCHEMBL1495265 0.95 NAALAD2 (0.59) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL1374181 0.94 NAALAD2 (0.69) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL11032575 0.94 NAALAD2 (0.69) NAALAD2SLC7A5FOLH1YARS1ENPEP
Tyrosine SCHEMBL1495325 0.93 NAALAD2 (0.57) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL29349540 0.93 NAALAD2 (0.68) NAALAD2SLC7A5FOLH1ENPEPACE
SCHEMBL6378283 0.91 NAALAD2 (0.66) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL29538675 0.91 NAALAD2 (0.66) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL11886066 0.91 NAALAD2 (0.66) NAALAD2SLC7A5FOLH1YARS1ENPEP
SCHEMBL159463 0.91 NAALAD2 (0.69) NAALAD2SLC7A5FOLH1ENPEPACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9409939-B2 Quantification method for remaining liver function and novel liver receptor imaging agent INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2016-08-09 US disclosed
US-9226982-B2 Gall bladder imaging agent and its preparation method INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2016-01-05 US disclosed
US-20140186262-A1 NOVEL GALL BLADDER IMAGING AGENT AND ITS PREPARATION METHOD INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2014-07-03 US disclosed
US-8552163-B2 Liver-targeting agents and their synthesis JOHNS HOPKINS UNIVERSITY (US) 2013-10-08 US disclosed
US-20130225798-A1 QUANTIFICATION METHOD FOR REMAINING LIVER FUNCTION AND NOVEL LIVER RECEPTOR IMAGING AGENT INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2013-08-29 US disclosed
US-8435491-B2 Quantification method for remaining liver function and novel liver receptor imaging agent INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2013-05-07 US disclosed
US-20110097265-A1 QUANTIFICATION METHOD FOR REMAINING LIVER FUNCTION AND NOVEL LIVER RECEPTOR IMAGING AGENT INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2011-04-28 US disclosed
US-20110097264-A1 RADIOLABELING METHOD USING MULTIVALENT GLYCOLIGANDS AS HEPATIC RECEPTOR IMAGING AGENT INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2011-04-28 US disclosed
WO-2011038356-A2 NOVEL LIVER-TARGETING AGENTS AND THEIR SYNTHESIS JOHNS HOPKINS UNIVERSITY (US) 2011-03-31 WO disclosed
US-20110077386-A1 NOVEL LIVER-TARGETING AGENTS AND THEIR SYNTHESIS JOHNS HOPKINS UNIVERSITY (US) 2011-03-31 US disclosed